ES2698123T3 - Polímero anfifílico basado en ácido hialurónico, método de preparación y su aplicación - Google Patents

Polímero anfifílico basado en ácido hialurónico, método de preparación y su aplicación Download PDF

Info

Publication number
ES2698123T3
ES2698123T3 ES16734888T ES16734888T ES2698123T3 ES 2698123 T3 ES2698123 T3 ES 2698123T3 ES 16734888 T ES16734888 T ES 16734888T ES 16734888 T ES16734888 T ES 16734888T ES 2698123 T3 ES2698123 T3 ES 2698123T3
Authority
ES
Spain
Prior art keywords
nanoparticles
drug
added
lys
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16734888T
Other languages
English (en)
Spanish (es)
Inventor
Zhiyuan Zhong
Yinan Zhong
Fenghua Meng
Jiandong Yuan
Yangqing Huang
Jianwen Chi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brightgene Bio Medical Technology Co Ltd
Original Assignee
Brightgene Bio Medical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brightgene Bio Medical Technology Co Ltd filed Critical Brightgene Bio Medical Technology Co Ltd
Application granted granted Critical
Publication of ES2698123T3 publication Critical patent/ES2698123T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES16734888T 2015-01-07 2016-01-04 Polímero anfifílico basado en ácido hialurónico, método de preparación y su aplicación Active ES2698123T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510006737.9A CN104497171B (zh) 2015-01-07 2015-01-07 基于透明质酸的两亲聚合物、其制备方法与应用
PCT/CN2016/070032 WO2016110228A1 (fr) 2015-01-07 2016-01-04 Polymère amphiphile à base d'acide hyaluronique, son procédé de préparation et son application

Publications (1)

Publication Number Publication Date
ES2698123T3 true ES2698123T3 (es) 2019-01-31

Family

ID=52938636

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16734888T Active ES2698123T3 (es) 2015-01-07 2016-01-04 Polímero anfifílico basado en ácido hialurónico, método de preparación y su aplicación

Country Status (5)

Country Link
US (1) US10292940B2 (fr)
EP (1) EP3241852B1 (fr)
CN (1) CN104497171B (fr)
ES (1) ES2698123T3 (fr)
WO (1) WO2016110228A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104497171B (zh) * 2015-01-07 2017-05-10 博瑞生物医药（苏州）股份有限公司 基于透明质酸的两亲聚合物、其制备方法与应用
CN106750273B (zh) * 2017-03-20 2019-04-05 中国科学技术大学 一种嵌段聚合物肿瘤放疗增敏剂及其制备方法
CN108969484B (zh) * 2018-09-18 2020-11-03 烟台大学 一种靶向动脉粥样硬化斑块纳米材料的制备方法
CN111440840B (zh) * 2019-01-16 2024-04-26 上海交通大学 一种分析肿瘤细胞耐药性的方法
CN110251456B (zh) * 2019-06-06 2023-01-06 苏州大学 一种纳米凝胶的制备方法与应用
CN110511387B (zh) * 2019-08-30 2022-04-15 苏州大学 透明质酸-g-聚酪氨酸-硫辛酸共聚物、聚多肽纳米粒及其制备方法与应用
EP4077404A1 (fr) * 2019-12-20 2022-10-26 Massachusetts Institute of Technology Dérivés d'acide hyaluronique
CN111467500B (zh) * 2020-03-23 2022-08-09 北京工业大学 一种低氧双靶向性agt抑制剂偶联物及其制备方法与应用
CN112516329B (zh) * 2020-12-28 2024-02-20 南京宁丹新药技术有限公司 基于高分子前药的自组装组合药物载体及其应用
CN113018450B (zh) * 2021-05-24 2021-08-06 潍坊中医药产业技术研究院 一种具有肿瘤细胞和肿瘤相关成纤维细胞双靶向功能的药物载体、制备方法及应用
CN113797351B (zh) * 2021-09-30 2023-10-27 大连民族大学 一步法合成pH响应型的靶向透明质酸-鬼臼毒素前药胶束及其应用
CN115501204B (zh) * 2022-10-25 2023-07-21 河北工业大学 一种用于级联递送药物的透明质酸纳米给药系统的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20072416A1 (it) * 2007-12-21 2009-06-22 Sigea Srl Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
CN102212146B (zh) * 2009-07-23 2013-02-13 苏州大学 一种侧链用硫辛酸修饰的亲水性聚合物
CN101665569B (zh) * 2009-07-23 2011-09-28 苏州大学 侧链用硫辛酸修饰的亲水性聚合物及其制备和应用
KR101161640B1 (ko) * 2009-08-25 2012-07-02 서울과학기술대학교 산학협력단 리포산이 결합된 화합물과 이의 제조방법
FR2979539B1 (fr) * 2011-09-05 2013-09-27 Teoxane Composition sterile dermo-injectable
CN104497171B (zh) * 2015-01-07 2017-05-10 博瑞生物医药（苏州）股份有限公司 基于透明质酸的两亲聚合物、其制备方法与应用

Also Published As

Publication number Publication date
EP3241852B1 (fr) 2018-10-17
EP3241852A1 (fr) 2017-11-08
US20180092858A1 (en) 2018-04-05
CN104497171A (zh) 2015-04-08
WO2016110228A1 (fr) 2016-07-14
US10292940B2 (en) 2019-05-21
EP3241852A4 (fr) 2018-01-03
CN104497171B (zh) 2017-05-10

Similar Documents

Publication Publication Date Title
ES2698123T3 (es) Polímero anfifílico basado en ácido hialurónico, método de preparación y su aplicación
Zhong et al. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts
Luo et al. Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery
Kularatne et al. Targeting of nanoparticles: folate receptor
Liu et al. Dextran-based redox-responsive doxorubicin prodrug micelles for overcoming multidrug resistance
ES2364987T3 (es) Copolímero de bloques para conjugados de fármaco y sus composiciones farmacéuticas.
Peng et al. Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery
An et al. A sulfur dioxide polymer prodrug showing combined effect with doxorubicin in combating subcutaneous and metastatic melanoma
CN107669632B (zh) 药物载体、胶束、药物制剂、及其制备方法和用途
ES2431316T3 (es) Sistema de nanotransporte con arquitectura dendrítica
Kwag et al. Facile synthesis of multilayered polysaccharidic vesicles
Ma et al. Increased active tumor targeting by an αvβ3-targeting and cell-penetrating bifunctional peptide-mediated dendrimer-based conjugate
CN103656650B (zh) 一种pH敏感的脑部肿瘤双级靶向纳米递药系统及制备方法和应用
Qu et al. Targeted delivery of doxorubicin via CD147-mediated ROS/pH dual-sensitive nanomicelles for the efficient therapy of hepatocellular carcinoma
Ko et al. Tumor microenvironment-specific nanoparticles activatable by stepwise transformation
CN108948152A (zh) 一种两亲性穿膜肽键合物、其制备方法及用途
CN111481507B (zh) 一种酶促阳离子化脂质体及其应用
Zhong et al. Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy
KR101797829B1 (ko) 표면전하 전환형 약물전달용 나노입자 및 이의 제조방법
RU2451509C1 (ru) Противоопухолевый препарат
CN108126210A (zh) 一种单靶向还原响应囊泡纳米药物在制备脑肿瘤治疗药物中的应用
WO2014041231A1 (fr) Hydrogel utile comme support injectable destiné à une application en thérapie cellulaire et comme système de libération contrôlée de médicaments
ES2867398T3 (es) Nanosistemas para el transporte controlado de moléculas activas con fines diagnósticos, pronósticos y terapéuticos
Ma et al. Construction of glutathione-responsive paclitaxel prodrug nanoparticles for image-guided targeted delivery and breast cancer therapy
US10973762B2 (en) Active-targeting-type polymer derivative, composition containing said polymer derivative, and uses of said polymer derivative and said composition